Previous close | 20.30 |
Open | 20.30 |
Bid | 18.00 |
Ask | 22.70 |
Strike | 50.00 |
Expiry date | 2024-01-19 |
Day's range | 20.30 - 20.30 |
Contract range | N/A |
Volume | |
Open interest | N/A |
JERSEY CITY, N.J., September 27, 2023--Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice
Organon Canada, a subsidiary of Organon (NYSE: OGN), a global healthcare company with a focus on women's health, is declaring its support for universal access to contraception in Canada. In recognition of World Contraception Day on September 26, the company is joining a growing number of local organizations advocating for improved and equitable contraceptive access, education, and support for women in Canada and around the world.
JERSEY CITY, N.J., September 14, 2023--First Real-World Observational Study of the JADA® System, a Medical Device to Control PPH, Published in ACOG’s Obstetrics & Gynecology